FluMist Picks Up Insurance Reimbursement, CDC Endorsement After Outbreak
Executive Summary
MedImmune/Wyeth's FluMist has picked up insurance company support with a series of announcements from payors that they will reimburse members receiving FluMist vaccines
You may also be interested in...
MedImmune FluMist Sales Of $30 Mil. Expected; 50% Return Rate Possible
MedImmune expects to record about $30 mil. of sales-related revenue for the FluMist nasal flu vaccine during the 2003-2004 launch season
MedImmune FluMist Sales Of $30 Mil. Expected; 50% Return Rate Possible
MedImmune expects to record about $30 mil. of sales-related revenue for the FluMist nasal flu vaccine during the 2003-2004 launch season
FluMist discounts for health departments
State and local health departments can purchase up to 3 mil. doses of FluMist at $20 a dose versus the usual price of $46 a dose. HHS negotiated the contract with Wyeth/MedImmune for health departments to meet increased demand for flu vaccines (1"The Pink Sheet" Dec. 15, 2003, p. 33). If all 3 mil. doses were sold, the contract would represent the majority of the 4-5 mil. doses manufactured this year. Wyeth/MedImmune had been offering $25 rebate coupons following many insurance companies' initial reluctance to cover the vaccine (2"The Pink Sheet" Nov. 17, 2003, p. 35)...